Editas Medicine (EDIT) Free Cash Flow Growth (3y) (2018 - 2025)
Editas Medicine (EDIT) Free Cash Flow Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -5.05% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.07% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.71% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -10.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 13.88% |
| Jun 30, 2025 | -12.77% |
| Mar 31, 2025 | 3.14% |
| Dec 31, 2024 | -10.94% |
| Sep 30, 2024 | -9.88% |
| Jun 30, 2024 | -10.52% |
| Mar 31, 2024 | -0.55% |
| Dec 31, 2023 | 21.80% |
| Sep 30, 2023 | 13.57% |
| Jun 30, 2023 | -11.50% |
| Mar 31, 2023 | 12.82% |
| Dec 31, 2022 | -42.38% |
| Sep 30, 2022 | -18.35% |
| Jun 30, 2022 | -9.35% |
| Mar 31, 2022 | -20.09% |
| Dec 31, 2021 | -118.13% |
| Sep 30, 2021 | -72.25% |
| Jun 30, 2021 | -37.69% |
| Mar 31, 2021 | -28.62% |
| Sep 30, 2020 | -76.85% |